Part VI • Hand, Wrist, And Upper Extremity

Chapter 87: Targeted Muscle Reinnervation

Questions: 7
Answered: 0/7
Score: 0%
1 2 3 4 5 6 7
Question 1 of 7 DEMOGRAPHICS OF LIMB AMPUTATIONS
Which one of the following is true regarding limb amputations and their sequelae?
A
In the United States there are typically 40,000 new limb amputations performed per annum.
B
The most common reason for limb amputation is poorly managed diabetes.
C
More than three quarters of all limb amputees experience chronic localized phantom or residual limb pain.
D
Neuromas represent disorganized nerve fibers and are reliably treated with traditional surgical techniques.
E
Stump neuromas can have profoundly negative effects on the overall functional ability of a limb amputee.
✓ Correct Answer: E. Stump neuromas can have profoundly negative effects on the overall functional ability of a limb amputee.
Clinical Explanation

In the United States, there are approximately 185,000 amputations each year (not 40,000) and there are nearly 2 million amputees in total. Nearly half of all amputations occur following trauma or as part of oncologic treatment. The remaining cases are secondary to vascular disease, diabetes, infection, sepsis, and other vasculopathies.1 Between a quarter and a half of all amputee patients experience chronic localized pain secondary to symptomatic neuromas and/or phantom limb pain (PLP).2–6 Neuromas are disorganized bundles of nerve fibers that form at the end of a divided or damaged nerve secondary to aberrant nerve fiber regeneration. Their development can have a significant negative impact on the functional rehabilitation and overall outcome of patients with amputations because of chronic pain and subsequent problems with fitting of prosthetics. Management of troublesome neuromas and the pain they cause can be challenging with traditional medical and surgical approaches.

References:
  • 1. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the
  • United States: 2005 to 2050. Arch Phys Med Rehabil 2008;89(3):422–429
  • 2. Jensen TS, Krebs B, Nielsen J, Rasmussen P. Phantom limb, phantom pain and stump pain in amputees during the first
  • 6 months following limb amputation. Pain 1983;17(3):243–256
  • 3. Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical
  • characteristics and relationship to pre-amputation limb pain. Pain 1985;21(3):267–278
  • 4. Pierce RO Jr, Kernek CB, Ambrose TA II. The plight of the traumatic amputee. Orthopedics 1993;16(7):793–797
  • 5. Ducic I, Mesbahi AN, Attinger CE, Graw K. The role of peripheral nerve surgery in the treatment of chronic pain associated
  • with amputation stumps. Plast Reconstr Surg 2008;121(3):908–914, discussion 915–917
Question 2 of 7 INDICATIONS FOR TARGETED MUSCLE REINNERVATION
Which one of the following was the original primary indication for targeted muscle reinnervation (TMR)?
A
Reduce chronic pain after limb amputation
B
Provide intuitive control of upper limb prostheses
C
Accelerate wound healing after limb amputation
D
Enhance residual muscle function after limb amputation
E
Provide a more robust soft-tissue cover for the amputated limb
✓ Correct Answer: B. Provide intuitive control of upper limb prostheses
Clinical Explanation

TMR is a surgical procedure that was originally designed to provide intuitive control of upper limb prostheses following amputation, through transfer of residual nerves to otherwise redundant denervated target muscle. It was noticed early on that many TMR patients noted a reduction in pain, sometimes with complete resolution of neuroma-related pain in an affected limb following this procedure.1–6 A rabbit amputation model was subsequently developed to study the effects of TMR. This showed that after 10 weeks, transferred nerves were found to more closely resemble that of their uninjured counterparts than that of a neuroma.7 Since then, multicenter patient trials have shown that TMR provides a consistent long-term benefit of pain relief and symptoms associated with both symptomatic neuroma and phantom limb pain.8

References:
  • 1. Kuiken TA, Dumanian GA, Lipschutz RD, Miller LA, Stubblefield KA. The use of targeted muscle reinnervation for improved
  • myoelectric prosthesis control in a bilateral shoulder disarticulation amputee. Prosthet Orthot Int 2004;28(3):245–253
  • 2. Hijjawi JB, Kuiken TA, Lipschutz RD, Miller LA, Stubblefield KA, Dumanian GA. Improved myoelectric prosthesis control
  • accomplished using multiple nerve transfers. Plast Reconstr Surg 2006;118(7):1573–1578
  • 3. Kuiken TA, Miller LA, Lipschutz RD, et al. Targeted reinnervation for enhanced prosthetic arm function in a woman with a
  • proximal amputation: a case study. Lancet 2007;369(9559): 371–380
  • 4. O’Shaughnessy KD, Dumanian GA, Lipschutz RD, Miller LA, Stubblefield K, Kuiken TA. Targeted reinnervation to improve
  • prosthesis control in transhumeral amputees. A report of three cases. J Bone Joint Surg Am 2008;90(2):393–400
  • 5. Dumanian GA, Ko JH, O’Shaughnessy KD, Kim PS, Wilson CJ, Kuiken TA. Targeted reinnervation for transhumeral ampu-
  • tees: current surgical technique and update on results. Plast Reconstr Surg 2009;124(3):863–869
  • 6. Kuiken TA, Li G, Lock BA, et al. Targeted muscle reinnervation for real-time myoelectric control of multifunction artificial
  • arms. JAMA 2009;301(6):619–628
  • 7. Kim PS, Ko JH, O’Shaughnessy KK, Kuiken TA, Pohlmeyer EA, Dumanian GA. The effects of targeted muscle reinnervation
  • on neuromas in a rabbit rectus abdominis flap model. J Hand Surg Am 2012;37(8):1609–1616
  • 8. Valerio IL, Dumanian GA, Jordan SW, et al. Preemptive treatment of phantom and residual limb pain with targeted muscle
  • reinnervation at the time of major limb amputation. J Am Coll Surg 2019;228(3):217–226
Question 3 of 7 APPROACHES TO NEUROMA MANAGEMENT FOLLOWING AMPUTATION
What is the critical element of TMR that differentiates it from other neuroma operations?
A
It uses a minimally invasive approach.
B
It restores normal localized sensation.
C
It promotes organized nerve regeneration.
D
It promotes growth factors for accelerated healing.
E
It relies on the principles of Wallerian degeneration.
✓ Correct Answer: C. It promotes organized nerve regeneration.
Clinical Explanation

Coaptation of the amputated nerve stumps to recipient motor nerve branches in TMR encourages organized nerve regeneration into the denervated target muscles, thus preventing the chaotic and misdirected nerve growth that typically leads to neuroma formation. This critical element of nerve-to-nerve coaptation differentiates TMR from other neuroma operations where nerve ends may be buried in muscle or bone or left to retract in other soft tissue. The central principle underlying the nerve transfers in TMR surgery is to reestablish a function for the divided nerve. This surgery uses a normal open surgical approach and is not minimally invasive. It does not restore normal localized function, nor promote growth factors for healing. Wallerian degeneration occurs when a nerve is divided and there is degeneration of the proximal nerve back to the next node of Ranvier. This is a process that occurs predictably in peripheral nerve divisions irrespective of subsequent surgery. It is after this point that the TMR process and principles differ.1–4

References:
  • 1. Kim PS, Ko JH, O’Shaughnessy KK, Kuiken TA, Pohlmeyer EA, Dumanian GA. The effects of targeted muscle reinnervation
  • on neuromas in a rabbit rectus abdominis flap model. J Hand Surg Am 2012;37(8):1609–1616
  • 2. Souza JM, Fey NP, Cheesborough JE, et al. Advances in transfemoral amputee rehabilitation: early experience with tar-
  • geted muscle reinnervation. Curr Surg Rep 2014;2:51
  • 3. Bowen JB, Wee CE, Kalik J, Valerio IL. Targeted muscle reinnervation to improve pain, prosthetic tolerance, and biopros-
  • thetic outcomes in the amputee. Adv Wound Care (New Rochelle) 2017;6(8):261–267
Question 4 of 7 PREOPERATIVE ASSESSMENT IN TARGETED MUSCLE REINNERVATION
Prior to undertaking TMR in a limb amputee with neuroma pain, which one of the following would be most likely to help assess whether treatment will be effective?
A
Obtaining a magnetic resonance imaging scan (MRI).
B
Eliciting a Tinel’s sign in the affected limb during clinical examination.
C
Performing a steroid injection at the suspected neuroma site.
D
Injecting botulinum toxin to the suspected neuroma site.
E
Injecting lidocaine at the suspected neuroma site.
✓ Correct Answer: E. Injecting lidocaine at the suspected neuroma site.
Clinical Explanation

4. Ducic I, Mesbahi AN, Attinger CE, Graw K. The role of peripheral nerve surgery in the treatment of chronic pain associated with amputation stumps. Plast Reconstr Surg 2008;121(3):908–914, discussion 915–917 There are a number of things that are useful in the preoperative workup for TMR in patients with a painful neuroma. These start with an office consultation to discuss the procedure with the patient and set their expectations as well as perform a physical examination. A useful and reliable way to assess whether neuroma surgery is likely to be beneficial is to inject local anesthetic into the area where pain originates, i.e., around the presumed neuroma to assess the effects of doing so. Physical examination and palpation can guide the injection to the site of a neuroma. Tinel’s sign or ultrasound guidance can help with this. In essence, if the block proves effective, i.e., it alleviates the patient’s usual pain, then they may be a good candidate for TMR. This is probably the most useful single test to be performed preoperatively. An MRI may also be ordered if further visualization and characterization of the neuroma is required. It is useful for the patient to record a pain and medication diary, documenting daily symptoms, duration, intensity, and type of pain. This can help assess the effectiveness of surgery postoperatively by repeating the diary exercise. Neither injection of steroid or botulinum toxin would be helpful in this setting.1,2

References:
  • 1. Pet MA, Ko JH, Friedly JL, Mourad PD, Smith DG. Does targeted nerve implantation reduce neuroma pain in amputees?
  • Clin Orthop Relat Res 2014;472(10):2991–3001
  • 2. Souza JM, Cheesborough JE, Ko JH, Cho MS, Kuiken TA, Dumanian GA. Targeted muscle reinnervation: a novel approach
  • to postamputation neuroma pain. Clin Orthop Relat Res 2014;472(10):2984–2990
Question 5 of 7 SURGICAL TECHNIQUE FOR TARGETED MUSCLE REINNERVATION
When performing TMR which one of the following is true?
A
A nerve stimulator should be used to identify the peripheral nerve for transfer.
B
Nerve coaptation is best performed 1 cm proximal to the target muscle.
C
Care must be taken to avoid division of the target muscle nerve.
D
The nerve coaptation is best performed with individual fascicular repair.
E
A peripheral to motor nerve size discrepancy is generally well tolerated.
✓ Correct Answer: E. A peripheral to motor nerve size discrepancy is generally well tolerated.
Clinical Explanation

When performing TMR during or following amputation, there is normally a size discrepancy between the donor and target nerves because the motor nerve branches tend to be small, whereas the peripheral nerves tend to be far larger as they would originally have divided distally to form different individual nerves. This size discrepancy is generally well tolerated and the key point is to reestablish the higher-level functions of the major amputated peripheral nerve by giving this nerve somewhere to go. The peripheral nerves which are to be transferred are identified visually by careful dissection and without a nerve stimulator, but it is the target motor nerves which are identified with the aid of a nerve stimulator following their visualization. The motor nerve target is transected near its entry point to muscle, preserving only enough length to perform suture neurorrhaphy (~2 mm), as this gives the shortest distance for nerve regeneration to occur. The neurorrhaphy is performed end to end with an epineural suture technique. Individual fascicular or group fascicular coaptation is not normally required.1

References:
  • 1. Bowen JB, Wee CE, Kalik J, Valerio IL. Targeted muscle reinnervation to improve pain, prosthetic tolerance, and biopros-
  • thetic outcomes in the amputee. Adv Wound Care (New Rochelle) 2017;6(8):261–267
  • OUTCOMES FOLLOWING TARGETED MUSCLE REINNERVATION
  • 6. When considering the outcomes of TMR, which one of the following is true?
  • D. Evidence supports the incorporation of TMR at the time of primary amputation.
  • The rates of neuroma formation and the severity of the neuroma which develops are reduced when TMR is
  • performed as part of a primary limb amputation. For this reason, it should be considered in primary amputation
  • cases. Alternatively, where there has been neuroma development postamputation, TMR is indicated to address pain.
  • Phantom limb sensation will remain following TMR; however, phantom limb pain should improve in the first
  • 3 months following surgery. Analgesic requirements, particularly for opiates, normally decrease in the first few
  • months following TMR surgery. The use of a prosthesis is increased following TMR (not decreased) because of
  • the reduction in pain.1,2
  • 1. Bowen JB, Wee CE, Kalik J, Valerio IL. Targeted muscle reinnervation to improve pain, prosthetic tolerance, and biopros-
  • thetic outcomes in the amputee. Adv Wound Care (New Rochelle) 2017;6(8):261–267
  • 2. Valerio IL, Dumanian GA, Jordan SW, et al. Preemptive treatment of phantom and residual limb pain with targeted muscle
  • reinnervation at the time of major limb amputation. J Am Coll Surg 2019;228(3):217–226
Question 6 of 7 OUTCOMES FOLLOWING TARGETED MUSCLE REINNERVATION
When considering the outcomes of TMR, which one of the following is true?
A
Phantom limb sensation should progressively disappear postoperatively.
B
Phantom limb pain usually starts to improve 12 months postsurgery.
C
Analgesic requirements normally increase in the first few months postsurgery.
D
Evidence supports the incorporation of TMR at the time of primary amputation.
E
The need for a prosthesis following amputation is frequently reduced after TMR.
✓ Correct Answer: D. Evidence supports the incorporation of TMR at the time of primary amputation.
Clinical Explanation

6. Harris AM, Althausen PL, Kellam J, Bosse MJ, Castillo R; Lower Extremity Assessment Project (LEAP) Study Group. Com- plications following limb-threatening lower extremity trauma. J Orthop Trauma 2009;23(1):1–6

Question 7 of 7 TARGETED MUSCLE REINNERVATION IN BELOW-KNEE AMPUTATION
You are performing an elective below-knee amputation (BKA) in a 38-year-old patient following longstanding problems with foot and ankle instability and pain after major trauma. You decide to take a TMR approach in this case. Which one of the following muscles would be ideally indicated for nerve transfer of the tibial nerve?
A
Medial gastrocnemius
B
Semitendinosus
C
Gracilis
D
Peroneus brevis
E
Adductor longus
✓ Correct Answer: A. Medial gastrocnemius
Clinical Explanation

There are a number of recommended nerve transfer combinations in TMR in order to reduce the likelihood of symptomatic end neuroma. These relate to each individual amputation level. The recommended muscle sites for the tibial nerve in BKA are the soleus, tibialis posterior, and gastrocnemius. The semitendinosus is recommended for the common peroneal component of the sciatic nerve during above knee amputation, the gracilis is recommended for the saphenous nerve in the above knee amputation, and the peroneus brevis is indicated for the deep peroneal nerve in a BKA. However, many combinations of nerve transfer can provide the divided nerve with a target muscle and maintain the central principle of TMR: to reestablish the higher level functions of the major amputated peripheral nerve by giving this nerve a direction and function. Other popular combinations include those shown in Tables 87.1 through 87.5 Table 87.1 Nerve Transfers for Below-Knee Amputation TMR Donor Nerve Target Motor Nerve Branch Tibial Medial or lateral gastrocnemius Tibialis posterior Medial or lateral soleus Deep peroneal Tibialis anterior Peroneus longus Peroneus brevis Medial soleus Superficial peroneal Peroneus longus Peroneus brevis Sural Tibialis posterior Soleus Table 87.2 Nerve Transfers for Above-Knee Amputation TMR Donor Nerve Target Motor Nerve Branch Tibial component of sciatic nerve Biceps femoris Common peroneal component of sciatic nerve Semitendinosus Saphenous Gracilis Table 87.3 Nerve Transfers for Forequarter Amputation TMR Donor Nerve Target Motor Nerve Branch Median nerve Pectoralis major Musculocutaneous nerve Clavicular head nerve branch of pectoralis major Ulnar nerve Pectoralis minor Radial nerve Long thoracic Thoracodorsal Table 87.4 Nerve Transfers for Transhumeral Amputation TMR Donor Nerve Target Motor Nerve Branch Medial antebrachial cutaneous nerve End-to-side to motor nerve branch of distal brachialis Lateral antebrachial cutaneous nerve Motor nerve branch of radial nerve innervating brachialis (where present) or brachioradialis Median nerve Musculocutaneous nerve motor branch to short head of biceps brachii Ulnar nerve Musculocutaneous nerve motor branch to brachialis Musculocutaneous nerve End-to-side to musculocutaneous nerve motor nerve branch of long head of biceps brachii Radial nerve Motor nerve branch of lateral head of triceps Table 87.5 Nerve Transfers for Transradial Amputation TMR Donor Nerve Target Motor Nerve Branch Median nerve Flexor digitorum superficialis Ulnar Flexor carpi ulnaris Superficial radial nerve Anterior interosseous nerve Flexor digitorum profundus

🎉 Chapter Completed!

Proceed to Next Chapter → Back to All Chapters